Pinima Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.80 M
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 102.70%
- Profit Growth 323.11%
- Ebitda 91.33%
- Net Worth 41.70%
- Total Assets 42.78%
About Pinima Lifescience
Pinima Lifescience Private Limited (PLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 May 1995 and has a history of 29 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.80 M, as per Ministry of Corporate Affairs (MCA) records.
Nipa Piyush, Manish Goda, and Lina Goda serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51900MH1995PTC087983
-
Company No.
087983
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 May 1995
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Pinima Lifescience?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nipa Piyush
|
Director | 07-Oct-2002 | Current |
|
Manish Goda
|
Director | 01-Jun-2019 | Current |
|
Lina Goda
|
Director | 20-Jan-2022 | Current |
Financial Performance of Pinima Lifescience.
Pinima Lifescience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 102.7% increase. The company also saw a substantial improvement in profitability, with a 323.11% increase in profit. The company's net worth Soared by an impressive increase of 41.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pinima Lifescience?
Unlock access to Pinima Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Cox Research Centre Private LimitedNipa Piyush is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pinima Lifescience?
Unlock and access historical data on people associated with Pinima Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pinima Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pinima Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
